TWO SIGMA ADVISERS, LP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,451
-90.4%
33,500
-85.7%
0.00%
Q3 2022$36,000
-92.9%
234,400
-42.8%
0.00%
-100.0%
Q1 2022$508,000
-73.9%
410,000
-59.0%
0.00%
-80.0%
Q4 2021$1,948,000
-35.9%
998,800
-10.0%
0.01%
-37.5%
Q3 2021$3,040,000
+52.9%
1,109,500
+75.8%
0.01%
+60.0%
Q2 2021$1,988,000
+32.3%
631,000
-10.6%
0.01%
+25.0%
Q1 2021$1,503,000
+553.5%
705,700
+496.5%
0.00%
+300.0%
Q4 2020$230,000
+1050.0%
118,300
+310.8%
0.00%
Q3 2020$20,00028,8000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$32,135,00011.34%
VR Adviser, LLC 16,047,286$43,970,0005.65%
COMMODORE CAPITAL LP 5,123,509$14,038,0003.70%
Ghost Tree Capital, LLC 2,000,000$5,480,0001.60%
EPIQ PARTNERS, LLC 916,100$2,510,0001.16%
SILVERARC CAPITAL MANAGEMENT, LLC 707,733$1,939,0001.10%
SPHERA FUNDS MANAGEMENT LTD. 3,824,938$10,480,0000.88%
HighVista Strategies LLC 438,239$1,201,0000.80%
Nicholas Investment Partners, LP 2,786,354$7,635,0000.56%
NEA Management Company, LLC 16,302,596$44,669,0000.53%
View complete list of VISTAGEN THERAPEUTICS INC shareholders